Starpharma Holdings Limited (OTCMKTS:SPHRY – Get Free Report)’s stock price dropped 10.9% during mid-day trading on Thursday . The stock traded as low as $0.55 and last traded at $0.55. Approximately 13,834 shares changed hands during trading, an increase of 361% from the average daily volume of 3,001 shares. The stock had previously closed at $0.62.
Starpharma Stock Performance
The business has a 50-day simple moving average of $0.67 and a 200 day simple moving average of $0.65. The company has a debt-to-equity ratio of 0.07, a current ratio of 4.94 and a quick ratio of 4.58.
About Starpharma
Starpharma Holdings Limited, a biopharmaceutical company, engages in the research, development, and commercialization of dendrimer products for pharmaceutical, life-science, and other applications worldwide. The company offers VivaGel BV, a non-antibiotic vaginal gel for the treatment of bacterial vaginosis and prevention of recurrent BV; VIRALEZE, an antiviral nasal spray; and VivaGel condom, an antiviral condom.
Recommended Stories
- Five stocks we like better than Starpharma
- High Flyers: 3 Natural Gas Stocks for March 2022
- Micron Stock Under $100: Seize the AI-Driven Upside
- What Are Earnings Reports?
- AI’s Next Big Winners: 3 Small-Cap Stocks to Watch in 2025
- What is a Dividend King?
- SolarEdge Stock Climbs Back: Goldman Sachs Sees 40% Upside
Receive News & Ratings for Starpharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Starpharma and related companies with MarketBeat.com's FREE daily email newsletter.
